B46.1

Clinical Causes: Infection with fungi from the Mucorales order, such as Rhizopus, Mucor, and Rhizomucor. Compromised immune system, including uncontrolled diabetes, particularly diabetic ketoacidosis. Prolonged use of corticosteroids or other immunosuppressive therapies. Underlying health conditions like hematological malignancies, organ transplantation, or iron overload conditions. Trauma or damage to the nasal or facial tissues providing entry points for fungi.

Key Symptoms: Facial pain or swelling, often around the cheeks, eyes, or forehead. Nasal congestion or discharge, which may be bloody or blackish. Headache, often severe and localized. Fever and malaise indicating systemic infection. Visual disturbances or swelling around the eyes. Facial numbness or paralysis. Sinus tenderness and sinusitis-like symptoms. In advanced cases, neurological signs such as altered mental status or seizures.

Diagnosis Path: Diagnosing rhinocerebral mucormycosis involves a combination of clinical evaluation and laboratory tests. Doctors will perform a physical examination focusing on facial and sinus areas and may request imaging studies such as MRI or CT scans to assess the extent of tissue involvement and detect any signs of brain invasion. Confirmatory diagnosis is made through tissue biopsy and microscopic examination, which reveals characteristic fungal hyphae. Cultures may also be used to identify the specific fungal species involved.

Treatment Protocols: Antifungal medications: High-dose intravenous antifungals, such as amphotericin B, are the mainstay of therapy. Surgical debridement: Removal of necrotic tissue and infected areas helps to control the spread of the fungus. Managing underlying conditions: Proper control of diabetes or other immune-compromising factors is critical. Supportive care: Includes maintaining hydration, correcting electrolyte imbalances, and close monitoring of the patient’s condition. Adjunct therapies: In some cases, hyperbaric oxygen therapy has been considered to enhance tissue healing. Early and combined approach: The best outcomes are observed when antifungal therapy and surgical intervention are initiated promptly.